BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ImClone Systems 

440 Route 22 East

Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-541-8000 Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight

ImClone Systems is a wholly-owned subsidiary of Eli Lilly and Company and part of Lilly’s oncology business unit. Dedicated to changing the world of cancer care, ImClone is developing its robust pipeline of novel monoclonal antibodies to treat a broad range of tumor types. ImClone is headquartered in New Jersey, where it has one of the world’s largest state-of-the-art biologics manufacturing operations, and it has research laboratories in New York City as well as offices in Europe.

 Key Statistics


Email:
Ownership:

Web Site: ImClone Systems
Employees: 1,200
Symbol: LLY
 









 Company News
Convicted ImClone Systems (LLY) Boss Becomes Chief Of Innovation At Kadmon Corporation While Brother Harlan W. Waksal, M.D Takes CEO Post 9/24/2014 8:16:08 PM
Zymeworks Announces Strategic Collaboration With Eli Lilly and Company (LLY) Subsidiary ImClone Systems (LLY) To Develop Bi-specific Antibodies Using Zymeworks' Azymetric™ Platform 1/9/2014 8:13:24 AM
Third Rock Ventures Taps Alnylam Pharmaceuticals (ALNY) CEO, Genzyme Corporation (GENZ)-ImClone Systems (LLY) Vets, as Venture Partners 5/14/2013 7:57:36 AM
Circadian Technologies Limited (CIR.AX)'s Partner ImClone Systems Corporation (IMCL) Commences First Phase 1 Clinical Trial of VEGFR-3 Antibody IMC-3C5 4/6/2011 7:32:51 AM
Eli Lilly and Company (LLY) Announces New Vice President of Oncology Research for ImClone Systems Corporation (IMCL) 3/10/2011 7:24:45 AM
ImClone Systems Corporation (IMCL) Ex-Chief Embarks on New Biotech Venture, Kadmon Pharmaceuticals 11/1/2010 7:58:11 AM
ImClone Systems Corporation (IMCL) Manufacturing Facility Shutting Down, 140 People Affected 8/23/2010 8:32:42 AM
Molecular Templates Inc. and ImClone Systems Corporation (IMCL) Form Oncology Drug Discovery and Translation Research Collaboration 7/6/2010 11:35:11 AM
Eli Lilly and Company (LLY)'s ImClone Systems Corporation (IMCL) Chops Drug Safety Jobs 4/22/2010 7:04:50 AM
ImClone Systems Corporation (IMCL) Founder Waksal Forming New Biotech Venture 2/23/2010 11:09:18 AM
12345678910...